{
    "name": "atropine ophthalmic",
    "comment": "Rx",
    "other_names": [
        "IsoptoAtropine"
    ],
    "classes": [
        "Cycloplegics/Mydriatics",
        "Anticholinergic Agents",
        "Ophthalmic"
    ],
    "source": "https://reference.medscape.com/drug/atropine-ophthalmic-343612",
    "pregnancy": {
        "common": [
            "There are no adequate and well-controlled studies in pregnant women to inform a drug-associated risk; adequate animal development and reproduction studies have not been conducted with atropine sulfate; in humans, 1% atropine sulfate is systemically bioavailable following topical ocular administration; the drug should only be used during pregnancy if the potential benefit justifies potential risk to fetus"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "There is no information to inform risk regarding presence of drug in human milk following ocular administrations of the drug to the mother; effects on breastfed infants and effects on milk production are also unknown",
            "Developmental and health benefits of breastfeeding should be considered along with the motherâ€™s clinical need for the drug and any potential adverse effects on breastfed child from the drug"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity or known allergic reaction to any ingredient of the formulation"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Elevation in blood pressure from systemic absorption reported following conjunctival instillation of recommended doses of this medication",
                "Although mydriatic/cycloplegic effects last for up to 2 wk in an uninflamed eye, an inflamed eye may require 2-4 times DAILY dosing to see an effective pharmacologic effect",
                "Nor for injection; topical use only",
                "While pupils are dilated patients are advised not to engage in hazardous activities like driving",
                "Administration to infants requires caution; may produce systemic symptoms (discontinue medication if this occurs"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Local irritation",
            "percent": null
        },
        {
            "name": "Hyperemia",
            "percent": null
        },
        {
            "name": "Edema",
            "percent": null
        },
        {
            "name": "Dry eyes",
            "percent": null
        },
        {
            "name": "Exudate",
            "percent": null
        },
        {
            "name": "Follicular conjunctivitis",
            "percent": null
        },
        {
            "name": "Vascular congestion",
            "percent": null
        },
        {
            "name": "Dermatitis",
            "percent": null
        },
        {
            "name": "Blurred vision",
            "percent": null
        },
        {
            "name": "Hyperreactive response in Down",
            "percent": null
        },
        {
            "name": "s syndrome children",
            "percent": null
        },
        {
            "name": "atropine",
            "percent": null
        },
        {
            "name": "Drowsiness",
            "percent": null
        },
        {
            "name": "Increased intraocular pressure",
            "percent": null
        },
        {
            "name": "Physostigmine",
            "percent": null
        }
    ]
}